Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea
ConclusionThis large-scale PMS study demonstrated that regdanvimab was effective against COVID-19 progression and had an acceptable safety profile when used in real-world clinical practice.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Coronavirus | COVID-19 | Drugs & Pharmacology | Infectious Diseases | Intensive Care | Liver | Respiratory Medicine | SARS | South Korea Health | Study | Urology & Nephrology